News & Podcast
Stay up to date with the latest stories, deep-dives and interviews from the Munich startup ecosystem. From funding deals to founder portraits and tech trends.
3 Munich biotech startups awarded European Lifestars Awards
Three Munich startups impressed at this year’s European Lifestars Awards in London: Among all applications and nominees received, Scirhom, Catalym and Tubulis prevailed in their respective categories.
Series D funding for Catalym
The biotech startup Catalym successfully closes its Series D funding round for 138 million euros. The funding round was led by Canaan Partners and Bioqube Ventures.
How Munich biotech startups are fighting cancer
Munich is one of Germany’s leading biotech locations. Here, research is being conducted on a wide variety of medications and therapies, including against cancer. We present five startups in more detail.
Catalym secures 50 million euros
Catalym raises 50 million euros in a Series C round. The biotech startup based in Martinsried plans to invest the newly raised capital in further clinical testing of its drug candidate Visugromab.